A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo

Yijia Li(Unknown), Hua Yu(City Of Hope National Medical Center)
Molecular Therapy
July 31, 2024
Cited by 2


Related Papers